Invited Speakers


Anthony T. Barker, Ph.D.
Consultant Clinical Scientist
Department of Medical Physics and Clinical Engineering
Royal Hallamshire Hospital


Tony Barker is a Consultant Clinical Scientist in the Department of Medical Physics and Clinical Engineering at Sheffield Teaching Hospitals NHS Foundation Trust and a Professor Associate at the University of Sheffield U.K.. An engineer by training, he has carried out research for over 35 years into the biological effects of electric and magnetic fields, encompassing possible health effects along with diagnostic and therapeutic applications.
Tony led the group in Sheffield which, over a ten year period, developed the first peripheral magnetic nerve stimulator and, in 1985, demonstrated the first magnetic stimulation of the brain. He has also been active in FES research and his group has published the first self-optimising stimulator for foot drop based on an automated electrode array technique.
He has a long-standing interest in the public understanding of science and has given many public lectures including the Faraday Lecture series, the Silvanus P. Thompson lecture series and a Royal Institution Discourse.
Tony is a Chartered Scientist and Engineer, a Fellow of the Institute of Physics and Engineering in Medicine and a Fellow of the Institution of Engineering and Technology, whose Biological Effects of Electromagnetic Fields Policy Advisory Group he chairs.



Marom Bikson, Ph.D.
Associate Professor of Biomedical Engineering
The City College of The City University of New York


Dr. Marom Bikson is a Cattell Associate Professor of Biomedical Engineering at The City College of New York (CCNY) of the City University of New York (CUNY) and co-Director of the Neural Engineering Group at the New York Center for Biomedical Engineering. The translational R&D activity of his group spans pre-clinical studies,computational models, device design and fabrication, regulatory activities, and clinicaltrials. Technologies developed by his group are in clinical trials in over 100 medicalcenters and include neuromodulation interventions for neuropsychiatric disorders, intra- and post-operative sensors, and surgeon training simulators. Dr. Bikson has published over 150 papers and book-chapters and is inventor on over 30 patent applications. He is known for his work on brain targeting with electrical stimulation, cellular physiology of electric effects, and electrical safety. Dr. Bikson co-invented High-Definition transcranial Direct Current Stimulation (HD-tDCS), the first non-invasive, targeted, and low-intensity neuromodulation technology. Dr. Bikson consults for medical technology companies and regulatory agencies on the design, validation, and certification of medical instrumentation. Dr. Bikson is co-founder of Soterix Medical Inc. and WiPOX LLC. Prior to becoming faculty at CUNY, Dr. Bikson was a research fellow at the University of Birmingham Medical School, UK and a Research Associate at Sontra Medical LLC, in Cambridge Mass. Dr. Bikson received a Ph.D. in Biomedical Engineering from Case Western Reserve University, in Cleveland OH, and a B.S. in Biomedical Engineering from Johns Hopkins University, Baltimore MD.



Rafael Carbunaru, Ph.D.
Vice President, Research & Development
Boston Scientific Neuromodulation


Rafael Carbunaru has been with Boston Scientific since 1999 and Vice President of Research and Development since October of 2011. He provides overall leadership, vision, inspiration and motivation to the R&D team located in Valencia, California. He also helps define and execute the pipeline of Neuromodulation products in SCS, DBS and other indications.
Prior to this role, Rafael was the R&D Director of Emerging Indications, where he led the development of microstimulation and MRI compatible technologies, as well as supporting clinical trials in migraine and overactive bladder, among others.
Rafael holds a Ph.D. and M.Sc. in Biomedical Engineering (with emphasis in neuromodulation) from Case Western Reserve University (Cleveland, Ohio) and an Electrical Engineering degree from Universidad Simon Bolivar (Venezuela). Rafael holds over 20 patents.


Tim Denison, Ph.D.
Technical Fellow
Director of Core Technology for the Neuromodulation Division
Medtronic, Inc.


Tim Denison is a Technical Fellow at Medtronic and Director of Core Technology for the Neuromodulation Division, where he helps oversee the design of next generation neural interface and algorithm technologies for the treatment of chronic neurological disease. In 2012, he was awarded membership to the Bakken Society, Medtronic's highest technical and scientific honor. Tim received an A.B. in Physics from The University of Chicago, and an M.S. and Ph.D. in Electrical Engineering from MIT. Tim's extracurricular pursuits include serving as an adjunct assistant professor at Brown University, teaching "smart" medical sensor design short courses at the TU Delft, chairing the IEEE EMBS society Twin Cities chapter.


Dominique M. Durand, Ph.D.
Linsedth Professor of Biomedical Engineering and Neurosciences
Director of the Neural Engineering Center
Case Western Reserve University


Dominique M. Durand is E.L. Linsedth Professor of Biomedical Engineering and Neurosciences and Director of the Neural Engineering Center at Case Western Reserve University in Cleveland, Ohio. He received an engineering degree from Ecole Nationale Superieure d'Electronique, Hydrolique, Informatique et Automatique de Toulouse, France in 1973. In 1974, he received a M.S. degree in Biomedical Engineering from CWRU in Cleveland OH., worked several years and in 1982 received a Ph.D. in Electrical Engineering from the University of Toronto in the Institute of Biomedical Engineering. He received an NSF Young Investigator Presidential Award as well as the Diekhoff and Wittke awards for graduate and undergraduate teaching and the Mortar board top-prof awards at CWRU. He is an IEEE Fellow and also Fellow of the American Institute for Medical and Biomedical Engineering and Fellow of the Institute of Physics. He serves on several editorial boards of peer-reviewed scientific journals and he is the editor-in-chief and founding editor of the Journal of Neural Engineering. His research interests are in neural engineering and include computational neuroscience, neurophysiology and control of epilepsy, non-linear dynamics of neural systems, neural prostheses and applied magnetic and electrical field interactions with neural tissue.



Brian Herman, Ph.D.
Vice President of Research
University of Minnesota


Dr. Brian Herman was appointed Vice President for Research at the University of Minnesota on January 1, 2013. He is responsible for the oversight and administration of externally funded research on the five campuses of the U of M system. He has primary responsibility for the overall vitality of the University-wide research environment, including supporting evolution of new research, maintaining a competitive research infrastructure, developing and managing campus-wide research policies, and overseeing administrative management of all sponsored research activity. He is also responsible for technology commercialization activities and for the administration of regulatory offices associated with research.
Dr. Herman received his undergraduate degree in Biology from Adelphi University and his doctorate from the University of Connecticut Health Science Center. He undertook postgraduate training at Harvard Medical School. Following, he joined the faculty at the University of North Carolina at Chapel Hill School of Medicine. He assumed the position of Professor and Chair of the Department of Cellular and Structural Biology at the University of Texas Health Science Center at San Antonio (UTHSCSA) in June 1998 until October 2004, when he assumed the position of Vice President for Research at the UTHSCSA. From 2011-2013, Dr. Herman served as the University of Texas Chancellor's Health Fellow prior to assuming his current position. For more information about his accomplishments visit.



Kendall H. Lee, M.D., Ph.D.
Associate Professor, Neurosurgery, Physiology and Biomedical Engineering
Mayo Clinic


Kendall H. Lee, M.D., Ph.D., is a consultant in the Department of Neurologic Surgery with a joint appointment in the Department of Physiology & Biomedical Engineering at Mayo Clinic and Director of Mayo Clinic Neural Engineering Laboratories.
Dr. Lee received the B.A. degree in biology and minor in philosophy from the University of Colorado at Denver. He attended Yale University Graduate School where he received the Master of Philosophy degree, the M.D. degree and the Ph.D. degree in neurobiology. He completed an internship in internal medicine at the Hospital of St. Raphael, Yale University School of Medicine and a residency year in neurology at Harvard Medical School. He furthered trained at Dartmouth Hitchcock Medical Center completing an internship in general surgery, a residency in neurosurgery and chief residency in neurosurgery.
In his clinical practice, Dr. Lee is an expert on neurological disorders seeing patients with Parkinson's Disease, Tourette's Syndrome, dystonia and other neurodegenerative and psychiatric diseases. He is leading research efforts at Mayo Clinic to develop a device called the Wireless Instantaneous Neurotransmitter Concentration System (WINCS), which can monitor and record electrical/chemical reactions in the brain during deep brain stimulation (DBS). WINCS will allow physicians to establish a precise relationship between stimulation and the resulting amount and type of chemicals the brain releases during DBS, in effect, making DBS less of a guessing game. This technology will provide a powerful new tool for intraoperative neurochemical monitoring for use during functional neurosurgery. Dr. Lee is also a commander in the United States Navy Reserve.


Andres Lozano, M.D., Ph.D.
RR Tasker Professor and Chairman of Neurosurgery
University of Toronto and the Toronto Western Hospital


Andres Lozano is Professor and Chairman of Neurosurgery at the University of Toronto and holds both the RR Tasker Chair in Functional Neurosurgery and a Tier 1 Canada Research Chair in Neuroscience.
He is best known for his work in Deep Brain Stimulation (DBS). His team has mapped out cortical and subcortical structures in the human brain and have pioneered applications of DBS for various disorders including Parkinson's disease, depression, dystonia, anorexia, Huntington's and Alzheimer's disease.
Dr. Lozano has over 400 publications, serves on the board of several international organizations and is a founding member of the scientific advisory board of the Michael J Fox Foundation. He has received a number of awards including the Margolese National Brain Award, Olivecrona medal and the Pioneer in Medicine award, has been elected a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences and has received the Order of Spain.



Kip Ludwig, Ph.D.
Program Director, Neural Engineering
National Institutes of Health, NINDS


Dr. Kip Ludwig joined the National Institute for Neurological Disorders and Stroke (NINDS) as the Program Director for Neural Engineering in 2011, and leads the NINDS Advanced Neural Prosthetics Research and Development Program. He received his Ph.D. in Biomedical Engineering at the University of Michigan, followed by post-doctoral work at the same institution. Dr. Ludwig's academic work included neural decoding algorithms for brain-computer interfaces (BCI), signal processing techniques to denoise neural recordings, and advanced materials to improve the chronic stimulating and recording performance of microelectrodes. More recently he worked in industry as a research scientist, where his team conceived, developed and demonstrated the chronic efficacy of a next-generation neural stimulation electrode for reducing blood pressure in both pre-clinical and clinical trials. Through this work Dr. Ludwig oversaw several good laboratory practice (GLP) and non-GLP studies supporting both European and FDA Investigational Device Exemption (IDE) human trials, as well as participated in the protocol development and execution of those trials, recently leading to approval for sale in the European Union. His interests are in all aspects of neural engineering, with special emphases on neuromodulation, BCI devices, and neural interface technology for translational development.


Helen S. Mayberg, M.D.
Professor, Psychiatry, Neurology and Radiology
Dorothy C. Fuqua Chair in Psychiatric Neuroimaging and Therapeutics
Emory University School of Medicine


Helen S. Mayberg, M.D. is Professor of Psychiatry, Neurology and Radiology and the Dorothy Fuqua Chair in Psychiatry Imaging and Therapeutics at Emory University School of Medicine. She heads a multidisciplinary research team studying brain mechanisms mediating depression pathogenesis and antidepressant treatment response using multimodal neuroimaging and pioneered the development of deep brain stimulation for treatment resistant depression.
In addition to ongoing studies to develop imaging biomarkers that can optimize treatment selection in individual depressed patients at all stages of illness, the lab is focused on the development of combined structural and electrical connectivity models to optimize surgical targeting, refine stimulation parameters and characterize mechanisms of both immediate and sustained antidepressant effects of high frequency DBS. Combined with real-time behavioral and physiological metrics, these studies offer a unique perspective on critical pathways and mechanisms mediating antidepressant effects of DBS, and on the pathophysiology of treatment resistant depression more generally.
Dr. Mayberg is a Board Certified Neurologist, trained at Columbia's Neurological Institute in New York, with fellowship training in nuclear medicine at Johns Hopkins. She is a member of the Institute of Medicine and is an active participant in a wide variety of advisory and scientific activities across multiple fields in neuroscience.



Gregory F. Molnar, Ph.D.
Director of Neuromodulation Research
Medtronic, Inc., Neuromodulation


As Director of the Neuromodulation Research department, Greg Molnar is responsible for providing strategic leadership to his team of 20 scientists to advance neurostimulation therapies for several neurological conditions including Parkinson's disease and other movement disorders, intractable pain, epilepsy, urinary incontinence, and gastric dysfunction. Greg oversees the progression of projects and scientific evidence relative to their phase-gate procedure to ensure timely execution of the group's numerous ongoing studies. Greg is also the primary physician contact involved with establishing and maintaining research collaborations. Currently, Greg serves as Chair for both the Non-Clinical Research Board and Brain Modulation Patent Board, and is a representative on the PRL Board of Directors, and Clinical Research Board, and externally on the Ontario Brain Institute Industry Advisory Board, and the Minnesota Neuromodulation Symposium program committee. In addition to his various research roles, Greg is a strong advocate for innovation, championing the Innovation Room and serving as Chair and Executive Sponsor of Innovation Week. Greg earned his M.Sc. and Ph.D. in Neuroscience/Clinical Neurophysiology from the University of Toronto/Toronto Western Research Institute where his research focused on the mechanism of action of Deep Brain Stimulation for movement disorders, chronic pain, and epilepsy. Greg also remains an active neuroscientist as part of his leadership role, publishing and participating in international conferences. Greg has been with Medtronic since 2005.



Randy Nelson , Ph.D.
Founder & President
Evergreen Medical Technologies


ARandall Nelson is founder and President of Evergreen Medical Technologies, Inc., a contract development and manufacturing company for medical devices located in St. Paul, Minnesota. Mr. Nelson is also President of PhysioTest, a wholly owned subsidiary of Evergreen Medical, an independent test lab providing contract testing services for medical devices.
Mr. Nelson has been responsible for the development of medical devices for over 30 years at both emerging and larger medical device companies. Mr. Nelson has held management positions at St. Jude Medical Inc., Boston Scientific Corporation, Angeion Corporation; and Cardiac Pacemakers, Inc.
Mr. Nelson has 13 issued patents. He has a Mechanical Engineering degree from the University of Minnesota and an Economics degree from Willamette University in Salem, Oregon. Mr. Nelson is also an Adjunct Faculty member of the Carlson School of Management, University of Minnesota, where he teaches a graduate level course in the valuation of new medical innovations. .


Annie Saha
Acting director
External Expertise and Partnerships


Anindita (Annie) Saha is the Acting Director of External Expertise and Partnerships (EEP) in the FDA's Center for Devices and Radiological Health (CDRH). EEP coordinates public-private partnerships, the Critical Path and Regulatory Science Initiatives, the Medical Device Fellowship Program, and technology transfer and collaboration efforts for the Center. EEP is also actively involved in the Network of Experts program and the Center's Patient Preference Initiative. Ms. Saha began her FDA career in 2005 as a researcher in the CDRH's Office of Science and Engineering Laboratories in the Division of Imaging and Applied Mathematics in the areas of imaging display technologies before moving to EEP to coordinate Critical Path and Regulatory Science activities for the Center. Ms. Saha has a Bachelor of Science in Bioengineering and Minor in History from the University of Pittsburgh. She was a student researcher at the McGowan Institute for Regenerative Medicine working in tissue engineering and wound healing.



Dirk Smith
Chief Technical Officer & Chief Human Resource Officer


Dirk Smith has 25 years of experience in the medical device field in technical leadership as well as product and business development. Dirk is one of the founders of Minnetronix along with Rich Nazarian and Jonathan Pierce, and has served in both engineering and business management roles. He now acts as Chief Technical Officer and Chief Human Resource Officer. Prior to founding Minnetronix, Dirk was a product development specialist at 3M.
Dirk graduated from the University of Iowa with a BS in Electrical Engineering and earned an MS in Electrical Engineering from the University of Minnesota. Throughout his career, Dirk has worked on numerous medical devices and instruments including infusion pumps, blood pumps and flow meters, oxygen saturation and hematocrit monitors, coagulation management systems and tissue ablation systems. He is an inventor on seven patents and the author of several papers and presentations on medical device design and product development.


Douglas Weber, Ph.D.
Program Manager
DARPA Microsystems Technology Office


Weber joined the DARPA Microsystems Technology Office (MTO) as a Program Manager in 2013. He is currently managing MTO's Reliable Neurotechnology (RE-NET) programs, which aim to advance the performance and durability of neural interface microsystems for controlling and sensing advanced upper extremity prosthetic limbs. Dr. Weber came to DARPA from the University of Pittsburgh, where he is on leave from his position as Associate Professor in the Department of Bioengineering and the Department of Physical Medicine and Rehabilitation. He also served the U.S. Department of Veterans Affairs (VA) as a Research Biomedical Engineer in the VA Pittsburgh Health System. His research interests include motor control neurophysiology and applications to neural prosthetics. Dr. Weber is a member of the Society for Neuroscience and a senior member of the Institute for Electrical and Electronics Engineers. He has published extensively in peer-reviewed journals and has mentored several undergraduate and graduate students in bioengineering, medical students and postdoctoral fellows. He holds a Bachelor of Science degree in Biomedical Engineering from the Milwaukee School of Engineering and Master of Science and Doctor of Philosophy degrees in Bioengineering from Arizona State University. He completed post-doctoral training in the Centre for Neuroscience at the University of Alberta.





Copyright © 2014 Regents of the University of Minnesota - All rights reserved.